Type 1 Diabetes

In-Hospital Tramadol Use Increases Hypoglycemia Risk in T1D, T2D

In-Hospital Tramadol Use Increases Hypoglycemia Risk in T1D, T2D

Results indicate that blood glucose monitoring should be conducted in hospitalized patients with diabetes.

Peptide Immunotherapy for Type 1 Diabetes: A Promising New Treatment

Peptide Immunotherapy for Type 1 Diabetes: A Promising New Treatment

By

Peptide immunotherapy may offer a personalized approach to modulating the immune response in persons with type 1 diabetes.

No Fingerstick Necessary: FDA Approves Novel Continuous Glucose Monitoring System for Diabetes

No Fingerstick Necessary: FDA Approves Novel Continuous Glucose Monitoring System for Diabetes

By

New monitoring system involves the placement of a small sensor wire beneath the skin surface to continuously monitor glucose levels.

Strategies for Multivessel Revascularization in T1D: CABG vs PCI

Strategies for Multivessel Revascularization in T1D: CABG vs PCI

PCI has been linked to increased risk of CHD, mortality, MI, and repeat revascularization in type 1 diabetes.

T1D  Risk Increased Following Influenza A H1N1 Diagnosis in Children

T1D Risk Increased Following Influenza A H1N1 Diagnosis in Children

By

The 2009 H1N1 swine flu pandemic has been linked to an increased risk of new-onset type 1 diabetes in children.

Glycemic Control in Physically Active Adolescents With T1D: Closed-Loop Control vs Remote Pump in Winter Sports

Glycemic Control in Physically Active Adolescents With T1D: Closed-Loop Control vs Remote Pump in Winter Sports

During a 5-day ski camp, researchers examined closed-loop insulin management vs a remote monitored pump system for glycemic control with the additional challenge of cold and altitude.

Cardiovascular, Renal Outcomes in Type 1 Diabetes

Cardiovascular, Renal Outcomes in Type 1 Diabetes

By

More awareness for afib risk factors including age, severity of complications, and glycemic status are needed.

Genetic Influence for Late-In-Life T1D Examined

Genetic Influence for Late-In-Life T1D Examined

By

High-risk genotypes represent 6.4% of the included study population, but accounted for 61% of all cases of T1D.

Celiac Disease in T1D: International Analysis of Disease Prevalence

Celiac Disease in T1D: International Analysis of Disease Prevalence

Prevalence of celiac disease in type 1 diabetes was higher in girls than in boys.

Reducing Hypoglycemia in T1D and T2D: Insulin Degludec vs Insulin Glargine

Reducing Hypoglycemia in T1D and T2D: Insulin Degludec vs Insulin Glargine

By

Compared with insulin glargine, insulin degludec significantly reduced rates of hypoglycemia in patients with either type 1 or type 2 diabetes.

Positive Islet Autoantibody Tests Up Parental Anxiety in T1D

Positive Islet Autoantibody Tests Up Parental Anxiety in T1D

Parents of children with an increased genetic risk for type 1 diabetes had higher level of anxiety.

Efficacy of Biomarker Screening Pathway in Monogenic Diabetes Diagnosis

Efficacy of Biomarker Screening Pathway in Monogenic Diabetes Diagnosis

By

Patients with assumed monogenic diabetes were examined using a novel 3-part biomarker screening pathway to detect incorrectly diagnosed cases of type 1 diabetes.

Management of Hypoglycemia: Insulin Degludec vs Insulin Glargine

Management of Hypoglycemia: Insulin Degludec vs Insulin Glargine

By

Expert Q&A compares the effects of insulin degludec and insulin glargine U100 in patients with type 1 and type 2 diabetes.

Exercise Training Intervention Improves Ventricular Function in Adolescent T1D

Exercise Training Intervention Improves Ventricular Function in Adolescent T1D

Left ventricular function can be improved, but not normalized, in adolescents with type 1 diabetes.

Lusduna Nexvue Follow-On Biologic Tentatively Approved by FDA

Lusduna Nexvue Follow-On Biologic Tentatively Approved by FDA

By

Tentative FDA approval has been granted to Merck's follow-on biologic basal insulin injection.

Racial Differences in HbA1c Readings Examined

Racial Differences in HbA1c Readings Examined

Long-term differences in HbA1c readings were larger than expected in black vs white patients.

Diabetes and Mental Illness: How Are They Linked?

Diabetes and Mental Illness: How Are They Linked?

By

The prevalence of diabetes and impairment in glucose metabolism are noticeably higher in psychiatric patients.

Hand Osteoarthritis and Type 1 Diabetes: Is There A Connection?

Hand Osteoarthritis and Type 1 Diabetes: Is There A Connection?

By

Hand pain, disability, and stiffness were common in long-term type 1 diabetes.

Reversing Type 1 Diabetes May Be Possible With Tuberculosis Vaccine

Reversing Type 1 Diabetes May Be Possible With Tuberculosis Vaccine

By

Data from a phase 1 study was presented at the 2017 ADA Scientific Sessions.

Prevalence of Celiac Disease Varies in Type 1 Diabetes

Prevalence of Celiac Disease Varies in Type 1 Diabetes

Over 3% of study participants with type 1 diabetes also had biopsy-confirmed celiac disease.

Eye Care in T1D: Guiding Retinopathy Screening Using HbA1c

Eye Care in T1D: Guiding Retinopathy Screening Using HbA1c

New recommendations suggest that frequency of diabetic retinopathy screening should be guided by patients' HbA1c levels.

CVD Risk Management in Type 1 Diabetes Improved With Metformin

CVD Risk Management in Type 1 Diabetes Improved With Metformin

By

Although metformin did not improve glycemic control in patients with type 1 diabetes, the treatment did improve cardiovascular disease risk management.

Diabetic Ketoacidosis in Pregnancy May Lead to Fetal Death

Diabetic Ketoacidosis in Pregnancy May Lead to Fetal Death

Diabetic ketoacidosis led to fatal demise, preterm birth, and neonatal intensive care unit admissions.

Hypoglycemia Effectivey Managed With New Nasal Glucagon Device

Hypoglycemia Effectivey Managed With New Nasal Glucagon Device

Hypoglycemic episodes, moderate or severe, can effectively and efficiently be managed by nasal glucagon in adult patients with type 1 diabetes.

Mental Health Screenings in Pediatric Patients With Type 1 Diabetes

Mental Health Screenings in Pediatric Patients With Type 1 Diabetes

By

Mental health and behavioral screenings should be routine part of care for pediatric patients with diabetes

New Point-of-Care C Peptide Test Shows Promise

New Point-of-Care C Peptide Test Shows Promise

By

A new point-of-care C peptide test may increase ease and access to testing for patients with type 1 and type 2 diabetes.

What Factors Increase Quality of Life in Teens With T1D?

What Factors Increase Quality of Life in Teens With T1D?

In all groups of participants, a lower HbA1c was associated with a better health-related quality of life in type 1 diabetes.

Reduced Awareness of Hypoglycemia in T1D With High-Intensity Interval Training

Reduced Awareness of Hypoglycemia in T1D With High-Intensity Interval Training

A single session of HIIT can "rapidly reduce" awareness of hypoglycemia in patients with type 1 diabetes.

American Diabetes Association 2017: Preview

American Diabetes Association 2017: Preview

By

First look at research to be presented at ADA 2017.

Fast-Acting Insulin Aspart for Glycemic Control in Type 1 Diabetes

Fast-Acting Insulin Aspart for Glycemic Control in Type 1 Diabetes

By

Both mealtime and postmeal faster insulin aspart are noninferior to mealtime conventional insulin aspart, regarding HbA1c change from baseline.

Sign Up for Free e-Newsletters